Related Experiment Video
Updated: Jul 22, 2025

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
Exosomal Long Noncoding RNAs in NSCLC: Dysfunctions and Clinical Potential
Hongze Lin1, Jiaying Li1, Maoye Wang2
1Department of Pulmonary and Critical Care Medicine, Yixing Hospital affiliated to Jiangsu University, Yixing 214200, China.
Exosomes, tiny vesicles in bodily fluids, carry long noncoding RNAs (lncRNAs) that drive non-small cell lung cancer (NSCLC) progression. These exosomal lncRNAs show promise as diagnostic biomarkers and therapeutic targets for NSCLC.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Exosomes are extracellular vesicles (EVs) mediating intercellular communication via human bodily fluids.
- Long noncoding RNAs (lncRNAs) are selectively packaged into exosomes, acting as crucial cargo.
- Exosomal lncRNAs play significant roles in cancer initiation and progression.
Purpose of the Study:
- To review the disordered functions of exosomal lncRNAs in non-small cell lung cancer (NSCLC).
- To summarize the potential clinical applications of exosomal lncRNAs in NSCLC diagnosis, prognosis, and therapy.
Main Methods:
- Literature review of current research on exosomal lncRNAs in NSCLC.
- Analysis of exosomal lncRNA roles in tumor proliferation, apoptosis, invasion, metastasis, angiogenesis, and treatment resistance.
- Evaluation of exosomal lncRNAs as diagnostic and prognostic biomarkers and therapeutic targets.
Main Results:
- Exosomal lncRNAs are implicated in regulating key aspects of NSCLC development and progression.
- Dysfunctional exosomal lncRNAs contribute to tumor initiation, growth, and resistance to therapy.
- These molecules influence the tumor microenvironment and angiogenesis.
Conclusions:
- Exosomal lncRNAs are critical players in NSCLC pathogenesis.
- They hold significant potential as non-invasive biomarkers for NSCLC diagnosis and prognosis.
- Targeting exosomal lncRNAs represents a promising therapeutic strategy for NSCLC.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
lncRNA - Long Non-coding RNAs
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Non-LTR Retrotransposons
MicroRNAs